R59, NOVN
Re, with positive phase 3, a public offering at $11, and analysts raising price targets to $35+ on average, why do you think the stock would be hard to borrow at TD Ameritrade ? Especially after the stock just went from $20 to $10 ! Seems to me, there has been a short attack on the stock, which hasn't abated yet.